{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:59:25Z","timestamp":1785434365433,"version":"3.56.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.yexcr.2007.03.018","type":"journal-article","created":{"date-parts":[[2007,3,31]],"date-time":"2007-03-31T07:19:02Z","timestamp":1175325542000},"page":"2378-2388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Membrane expression of DR4, DR5 and caspase-8 levels, but not Mcl-1, determine sensitivity of human myeloma cells to Apo2L\/TRAIL"],"prefix":"10.1016","volume":"313","author":[{"given":"Maria","family":"G\u00f3mez-Benito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Martinez-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Anel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Naval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2007.03.018_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1084\/jem.20011171","article-title":"Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development","volume":"195","author":"Takeda","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2007.03.018_bib2","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.4049\/jimmunol.175.9.5586","article-title":"Cutting edge: TRAIL deficiency accelerates hematological malignancies","volume":"175","author":"Zerafa","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2007.03.018_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.coph.2004.02.006","article-title":"Targeting death receptors in cancer with Apo2L\/TRAIL","volume":"4","author":"Kelley","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.yexcr.2007.03.018_bib4","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.leu.2401501","article-title":"TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells","volume":"13","author":"Gazitt","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.yexcr.2007.03.018_bib5","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1080\/1042819031000068052","article-title":"Role of Apo2L\/TRAIL and Bcl-2-family proteins in apoptosis of multiple myeloma","volume":"44","author":"Chen","year":"2003","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.yexcr.2007.03.018_bib6","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1517\/13543784.10.8.1521","article-title":"Concepts in the use of TRAIL\/Apo2L: an emerging biotherapy for myeloma and other neoplasias","volume":"10","author":"Mitsiades","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.yexcr.2007.03.018_bib7","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.277.5327.818","article-title":"Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors","volume":"277","author":"Sheridan","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2007.03.018_bib8","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/sj.leu.2402251","article-title":"TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy","volume":"15","author":"Lincz","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.yexcr.2007.03.018_bib9","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1074\/jbc.M410660200","article-title":"Receptor-selective mutants of apoptosis-inducing ligand 2\/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling","volume":"280","author":"Kelley","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2007.03.018_bib10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.cdd.4401649","article-title":"Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1","volume":"12","author":"MacFarlane","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexcr.2007.03.018_bib11","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood.V99.6.2162","article-title":"Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells","volume":"99","author":"Mitsiades","year":"2002","journal-title":"Blood"},{"issue":"3049","key":"10.1016\/j.yexcr.2007.03.018_bib12","first-page":"3050","article-title":"TRAIL-induced apoptosis of authentic myeloma cells does not correlate with the procaspase-8\/cFLIP ratio","volume":"100","author":"Spencer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2007.03.018_bib13","doi-asserted-by":"crossref","first-page":"10153","DOI":"10.1074\/jbc.M510349200","article-title":"Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis","volume":"281","author":"Han","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2007.03.018_bib14","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1182\/blood-2005-12-007971","article-title":"Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells","volume":"108","author":"Menoret","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2007.03.018_bib15","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1158\/0008-5472.CAN-03-2770","article-title":"Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells","volume":"64","author":"Taniai","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2007.03.018_bib16","doi-asserted-by":"crossref","first-page":"10491","DOI":"10.1074\/jbc.M412819200","article-title":"Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells","volume":"280","author":"Weng","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2007.03.018_bib17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V98.3.795","article-title":"TRAIL\/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications","volume":"98","author":"Mitsiades","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2007.03.018_bib18","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/75045","article-title":"Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand","volume":"6","author":"Jo","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2007.03.018_bib19","doi-asserted-by":"crossref","first-page":"RC209","DOI":"10.1523\/JNEUROSCI.22-04-j0001.2002","article-title":"Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain","volume":"22","author":"Dorr","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yexcr.2007.03.018_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(00)02659-3","article-title":"Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)","volume":"356","author":"Nitsch","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2007.03.018_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/86401","article-title":"Avoiding premature apoptosis of normal epidermal cells","volume":"7","author":"Qin","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2007.03.018_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86397","article-title":"Differential hepatocyte toxicity of recombinant Apo2L\/TRAIL versions","volume":"7","author":"Lawrence","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2007.03.018_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2567.1996.d01-782.x","article-title":"Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells","volume":"89","author":"Martinez-Lorenzo","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.yexcr.2007.03.018_bib24","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1038\/sj.leu.2402650","article-title":"Role of caspases and apoptosis-inducing factor (AIF) in cladribine-induced apoptosis of B cell chronic lymphocytic leukemia","volume":"16","author":"Perez-Galan","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.yexcr.2007.03.018_bib25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0014-5793(97)01282-9","article-title":"Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way","volume":"417","author":"Gamen","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yexcr.2007.03.018_bib26","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1016\/j.febslet.2005.10.007","article-title":"Apo2L\/TRAIL is an indirect mediator of apoptosis induced by interferon-alpha in human myeloma cells","volume":"579","author":"Gomez-Benito","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yexcr.2007.03.018_bib27","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1038\/sj.leu.2403970","article-title":"Growth factors and antiapoptotic signaling pathways in multiple myeloma","volume":"19","author":"van de Donk","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.yexcr.2007.03.018_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/bbrc.2001.5536","article-title":"Differential effects of filipin and methyl-beta-cyclodextrin on B cell receptor signaling","volume":"287","author":"Awasthi-Kalia","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2007.03.018_bib29","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1074\/jbc.M505688200","article-title":"Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis","volume":"281","author":"Clohessy","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2007.03.018_bib30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.cdd.4401669","article-title":"Taming TRAIL: the winding path to a novel form of cancer therapy","volume":"12","author":"Peter","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexcr.2007.03.018_bib31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/sj.cgt.7700792","article-title":"Mechanisms of resistance to TRAIL-induced apoptosis in cancer","volume":"12","author":"Zhang","year":"2005","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.yexcr.2007.03.018_bib32","doi-asserted-by":"crossref","first-page":"20968","DOI":"10.1074\/jbc.M414696200","article-title":"Phosphoinositide 3-kinase accelerates postoperative tumor growth by inhibiting apoptosis and enhancing resistance to chemotherapy-induced apoptosis. Novel role for an old enemy","volume":"280","author":"Coffey","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2007.03.018_bib33","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1038\/sj.onc.1204736","article-title":"Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer","volume":"20","author":"Chen","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2007.03.018_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.onc.1208213","article-title":"Amiloride augments TRAIL-induced apoptotic death by inhibiting phosphorylation of kinases and phosphatases associated with the P13K-Akt pathway","volume":"24","author":"Kim","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2007.03.018_bib35","doi-asserted-by":"crossref","first-page":"23319","DOI":"10.1074\/jbc.M910438199","article-title":"Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor","volume":"275","author":"Truneh","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.yexcr.2007.03.018_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-5793(01)03222-7","article-title":"The short splice form of Casper\/c-FLIP is a major cellular inhibitor of TRAIL-induced apoptosis","volume":"510","author":"Bin","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yexcr.2007.03.018_bib37","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.4049\/jimmunol.165.11.6293","article-title":"TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity","volume":"165","author":"Kirchhoff","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2007.03.018_bib38","doi-asserted-by":"crossref","first-page":"20633","DOI":"10.1074\/jbc.M101780200","article-title":"Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex","volume":"276","author":"Krueger","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2007.03.018_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35095508","article-title":"Regulation of lymphocyte proliferation and death by FLIP","volume":"1","author":"Thome","year":"2001","journal-title":"Nat. Rev., Immunol."},{"key":"10.1016\/j.yexcr.2007.03.018_bib40","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1093\/emboj\/cdf356","article-title":"c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis","volume":"21","author":"Chang","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.yexcr.2007.03.018_bib41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4049\/jimmunol.175.1.311","article-title":"Cellular FLIP long form augments caspase activity and death of T cells through heterodimerization with and activation of caspase-8","volume":"175","author":"Dohrman","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2007.03.018_bib42","doi-asserted-by":"crossref","first-page":"45162","DOI":"10.1074\/jbc.M206882200","article-title":"The long form of FLIP is an activator of caspase-8 at the Fas death-inducing. signaling complex","volume":"277","author":"Micheau","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2007.03.018_bib43","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1074\/jbc.M510863200","article-title":"The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases","volume":"281","author":"Eckelman","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2007.03.018_bib44","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.1038\/sj.onc.1208086","article-title":"Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells","volume":"23","author":"Delmas","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2007.03.018_bib45","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ymthe.2004.12.008","article-title":"Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts","volume":"11","author":"Vanoosten","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2007.03.018_bib46","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM199601183340308","article-title":"Antiepileptic drugs","volume":"334","author":"Brodie","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2007.03.018_bib47","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/mol.65.3.520","article-title":"Valproic acid inhibits angiogenesis in vitro and in vivo","volume":"65","author":"Michaelis","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yexcr.2007.03.018_bib48","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood-2003-08-2806","article-title":"IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL\/Apo-2 ligand) displaying apoptotic activity on leukemic cells","volume":"103","author":"Tecchio","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2007.03.018_bib49","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood.V99.6.1885","article-title":"Myeloid cell factor-1 is a critical survival factor for multiple myeloma","volume":"99","author":"Zhang","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2007.03.018_bib50","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cellsig.2006.10.009","article-title":"Mechanisms of apoptosis induced by IFN-alpha in human myeloma cells: role of Jak1 and Bim and potentiation by rapamycin","volume":"19","author":"G\u00f3mez-Benito","year":"2007","journal-title":"Cell. Signal."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448270700136X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448270700136X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T03:56:45Z","timestamp":1757995005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448270700136X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S001448270700136X"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2007.03.018","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Membrane expression of DR4, DR5 and caspase-8 levels, but not Mcl-1, determine sensitivity of human myeloma cells to Apo2L\/TRAIL","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2007.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}